Primary Category:
Treatment Protocols
Disease Category:
Skin
Status:
Temporarily Closed
STAMP: Surgically Treated Adjuvant Merkel cell carcinoma with Pembrolizumab, a Phase III Trial
NCT#03712605
Eligible for screening study DCP 001
EA6174 is temporarily closed to accrual, effective March 31, 2023.
